Evidence map›Paper›PMID 36781839›Full record

ArticleCell death & disease2023

m

Hua Guan, Kun Tian, Wei Luo, Mingfei Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. METTL3-dependent mJournal of translational medicine · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Circular RNAs: key players in tumor immune evasion.Molecular and cellular biochemistry · 2025
    Review
  9. Review
  10. Review
  11. Review
  12. Regulation and application of mScience China. Life sciences · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hua GuanDepartment of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Kun TianDepartment of Stomatology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Wei LuoDepartment of Stomatology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. phd_luowei_edu@yeah.net.
Mingfei LiDepartment of Hepatobiliary Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. limingfeiuestc@yeah.net.
University of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging evidence indicates the critical roles of N

Indexed as

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsB7-H1 AntigenCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansMethyltransferasesMyosin Type IRNA-Binding ProteinsRNA, CircularRNA, MessengerB7-H1 AntigenIGF2BP2 protein, humanMethyltransferasesMETTL3 protein, humanMYO1C protein, humanMyosin Type IRNA-Binding ProteinsRNA, CircularRNA, Messenger

Identifiers

PMID36781839
PMCPMC9925427
OpenAlexW4320709503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.